Key Metrics
MARKET CAP
$50.43B
P/E RATIO
47.5
BETA
0.94
Less volatile
DIV YIELD
N/A
52W HIGH
$87.89
52W LOW
$65.94
VOLATILITY
31.6%
30d annualized
Price Performance
30-DAY PRICE CHART
$83.60 → $85.90+2.75%
30 days agoToday
1-YEAR PERFORMANCE
$71.62 → $85.90+19.9%
EW | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Edwards Lifesciences is currently trading at $85.90, which is 2.3% below its 52-week high. With a beta of 0.94, the stock shows average sensitivity to market movements.
RSI (14)NEUTRAL
30-DAY TRENDNEUTRAL
VOLUME2.8M(Below avg)
Frequently Asked Questions
Is EW a good buy right now?
Edwards Lifesciences trades at 47.5x earnings. This is above market average, reflecting growth expectations. Current risk level is High based on 31.6% volatility.
Does EW pay dividends?
Edwards Lifesciences does not currently pay a regular dividend. The company may be reinvesting profits for growth.
How volatile is EW?
With 30-day annualized volatility of 31.6% and beta of 0.94,EW is classified as High risk. The stock tends to be more stable than the market average.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track EW Live
Add Edwards Lifesciences to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:41 PM